J. Biol. Chem., 2022 · DOI: https://doi.org/10.1016/j.jbc.2022.102443 · Published: August 31, 2022
Spinal cord injury (SCI) often results in nerve structure damage and nerve dysfunction. After SCI, neurons have limited neurite growth ability, hindering nerve function restoration. This study investigates the role of Triad1, an E3 ubiquitin ligase, in promoting neurite outgrowth after SCI by inhibiting MDM2-mediated ubiquitination of pleiotrophin (PTN). The research uses a SCI rat model and cultured rat astrocytes and neurons to systematically examine the effects of Triad1, MDM2, and PTN on astrocyte function, neurite outgrowth, and functional recovery after SCI.
Triad1 could be a potential therapeutic target for promoting nerve regeneration and functional recovery after spinal cord injury.
The finding that Triad1 inhibits MDM2-mediated PTN ubiquitination could lead to the development of drugs that enhance Triad1 activity.
The study suggests new strategies for SCI treatment focusing on promoting astrocyte-dependent neurite outgrowth.